© 2003 BMJ Publishing Group Ltd
RESEARCH PAPER
"A deep fragrance of academia": the Australian Tobacco Research Foundation
1 School of Public Health, University of Sydney, Sydney, New South Wales, Australia
2 Respiratory Unit, Repatriation Hospital, Concord, New South Wales, Australia
Correspondence to:
Correspondence to:
Professor Simon Chapman
School of Public Health, University of Sydney, Building A 27, Sydney, NSW 2006, Australia; simonchapman{at}health.usyd.edu.au
Objectives: (1) To review the history of the tobacco industry supported Australian Tobacco Research Foundation (ATRF)(19701994) for evidence of the industrys use of the Foundation to further its objectives that "more research was needed" on smoking and health and to promulgate the view that nicotine was not addictive. (2) To review efforts by public health advocates to discredit the ATRF as a public relations tool used by the Australian industry.
Methods: Systematic search of previously internal industry documents released through the US Master Settlement Agreement.
Results: The ATRF was headed by prestigious Australian medical scientists, with at least one considered by the industry to be "industry positive". An international ATRF symposium on nicotine was vetted by the industry and heavily attended by industry approved scientists. Following sustained criticism from the health and medical community about the industrys creation of the ATRF to further its objectives, the ATRFs scientific committee was provoked to publicly declare in 1988 that smoking was a causative agent in disease. This criticism led to growing ATRF boycotts by scientists and substandard applications, causing the industry to see the ATRF as being poor value-for-money and eventually abandoning it.
Conclusions: The raison detre for the ATRFs establishment was to allow the Australian industry to point to its continuing commitment to independent medical research, with the implied corollary that tobacco control measures were premature in the face of insufficient evidence about tobaccos harms. Sustained criticism of tobacco industry funded research schemes can undermine their credibility among the scientific community.
Keywords: tobacco industry; advocacy; industry sponsored research; nicotine addition
Abbreviations: ARISE, Association for Research into the Science of Enjoyment; ATRF, Australian Tobacco Research Foundation; CTR, Council for Tobacco Research; TIRC, Tobacco Industry Research Council; PM, Philip Morris; SHB, Shook, Hardy & Bacon
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
-
Kummerfeldt, C E, Barnoya, J, Bero, L
(2009). Philip Morris involvement in the development of an air quality laboratory in El Salvador. Tobacco Control
18: 241-244
[Abstract] [Full Text] -
Carter, S M, Chapman, S
(2003). Smoking, disease, and obdurate denial: the Australian tobacco industry in the 1980s. Tobacco Control
12: iii23-30
[Abstract] [Full Text] -
Chapman, S
(2003). "We are anxious to remain anonymous": the use of third party scientific and medical consultants by the Australian tobacco industry, 1969 to 1979. Tobacco Control
12: iii31-37
[Abstract] [Full Text]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
